Aquestive Therapeutics (AQST) EPS (Basic) (2018 - 2026)
Aquestive Therapeutics' (AQST) quarterly EPS (Basic) came in at -$0.07 in Q1 2026, up 72.63% year-on-year from -$0.04 in Q1 2025, and up 77.95% quarter-over-quarter from -$0.3 in Q4 2025.
Aquestive Therapeutics (AQST) EPS (Basic) (2018 - 2026) Analysis & Trends
Aquestive Therapeutics' EPS (Basic) history runs 9 years deep, the most recent figure standing at -$0.07 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 72.63% year-over-year to -$0.07 in Q1 2026; TTM through Mar 2026 was -$0.56, a 1.04% increase from a year earlier, with the FY2025 full-year figure at -$0.78, down 53.97% from the prior year.
- EPS (Basic) grew to -$0.07 in Q1 2026 per AQST's latest filing, from -$0.3 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.15 in Q1 2023 and bottomed at -$0.36 in Q2 2022.
- The 5-year median for EPS (Basic) is -$0.14 (2025), against an average of -$0.16.
- Across the five-year window, EPS (Basic) jumped 145.49% in 2023 and plunged 351.74% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$0.25 in 2022, then jumped by 47.76% to -$0.13 in 2023, then sank by 48.52% to -$0.2 in 2024, then plunged by 51.52% to -$0.3 in 2025, then jumped by 77.95% to -$0.07 in 2026.
- Per Business Quant, the three latest AQST EPS (Basic) figures stand at -$0.07 (Q1 2026), -$0.3 (Q4 2025), and -$0.14 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 6.32 |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 0.11 |
| 10 | Aquestive Therapeutics | 453.66 Mn | 453.66 Mn | 13.47 Mn | -0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.07 |
| Dec 31, 2025 | -0.30 |
| Sep 30, 2025 | -0.14 |
| Jun 30, 2025 | -0.14 |
| Mar 31, 2025 | -0.24 |
| Dec 31, 2024 | -0.20 |
| Sep 30, 2024 | -0.13 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.17 |
| Dec 31, 2023 | -0.13 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -0.10 |
| Mar 31, 2023 | 0.15 |
| Dec 31, 2022 | -0.25 |
| Sep 30, 2022 | -0.23 |
| Jun 30, 2022 | -0.36 |
| Mar 31, 2022 | -0.32 |
| Dec 31, 2021 | -0.76 |
| Sep 30, 2021 | -0.37 |
| Jun 30, 2021 | -0.33 |